Subscribe to RSS - Mick Farrell

Mick Farrell

ResMed says ‘innovation’ in masks pays off

Company also discusses software investments, competitive bidding

SAN DIEGO – ResMed’s masks and accessories hit constant currency growth of 19% in the U.S., Canada and Latin America for the second quarter of fiscal year 2020.

They hit growth of 16% globally.

ResMed reports double-digit growth, announces software acquisition


SAN DIEGO – ResMed reported net revenues of $736.2 million for the second quarter ended Dec. 31, 2019, compared to $651.1 million for the same period in 2018, a 13% increase.

ResMed CEO to ring Opening Bell


SAN DIEGO – ResMed CEO Mick Farrell will ring the Opening Bell at the New York Stock Exchange on Sept. 30 to celebrate 20 years of being listed on the NYSE and to commemorate ResMed’s 30th anniversary.

ResMed rides connected health wave overseas


SAN DIEGO – ResMed got a nice boost from Europe and Asia in the third quarter of fiscal year 2018, as growth in the U.S. slowed slightly.

ResMed highlights ‘positive’ tax changes


SAN DIEGO – Tax reform recently passed by Congress has “liberated our global cash assets to be able to be invested without artificial constraints,” ResMed CEO Mick Farrell said during a Jan. 22 conference call.

ResMed sets high expectations for mask sales

Company says it’s ready to ‘unleash’ sales force

SAN DIEGO – ResMed expects to see a nice bump in mask sales in the first quarter of its fiscal year 2018, now that it has manufacturing “sufficiently ramped up” for two new masks, the N20 and F20, says CEO Mick Farrell.

ResMed highlights Brightree’s contribution, mask growth in Q3


SAN DIEGO – It was Brightree that pushed ResMed into double-digit increases for revenues in the third quarter of fiscal year 2017.

Integration begins for ResMed

Company acquired Inova, Brightree in less than three-month span

SAN DIEGO – It’s still early days for recent acquisitions to impact ResMed’s financial results, but Inova Technologies helped to boost the company’s revenues by 2% in the third quarter of fiscal year 2016.

ResMed boosts revenue


SAN DIEGO – ResMed reported revenues of $453.9 million for the three months ended March 31, 2016, a 7% increase compared to the same period in 2015. Net income for the quarter was $88.5 million, a 3% decrease compared to the same period in 2015.

Health informatics: ResMed says it has ‘yearlong lead’


SAN DIEGO – The competition in health informatics-driven sleep therapy products is heating up, but ResMed officials say the company is in a good position because it had a head start.